Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Cash & Equivalents: 2012-2016

Historic Cash & Equivalents for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2016 value amounting to $12.1 million.

  • Tvardi Therapeutics' Cash & Equivalents rose 117.32% to $11.8 million in Q3 2017 from the same period last year, while for Sep 2017 it was $11.8 million, marking a year-over-year increase of 117.32%. This contributed to the annual value of $12.1 million for FY2016, which is 19.93% down from last year.
  • Latest data reveals that Tvardi Therapeutics reported Cash & Equivalents of $12.1 million as of FY2016, which was down 19.93% from $15.1 million recorded in FY2015.
  • Tvardi Therapeutics' Cash & Equivalents' 5-year high stood at $52.7 million during FY2014, with a 5-year trough of $1.1 million in FY2012.
  • Over the past 3 years, Tvardi Therapeutics' median Cash & Equivalents value was $15.1 million (recorded in 2015), while the average stood at $26.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 1,006.27% in 2013, then plummeted by 71.33% in 2015.
  • Over the past 5 years, Tvardi Therapeutics' Cash & Equivalents (Yearly) stood at $1.1 million in 2012, then skyrocketed by 1,006.27% to $12.4 million in 2013, then surged by 326.18% to $52.7 million in 2014, then plummeted by 71.33% to $15.1 million in 2015, then decreased by 19.93% to $12.1 million in 2016.